We’re Transforming Patient-Centered 
Care Through Technology and Design

Love Lifesciences is advancing care through responsible innovation— learning fast, acting ethically, and delivering solutions that genuinely improve patient lives.

We Deliver Patient-Centric Innovation - Because Every Dose Matters

Mission: Revolutionize the patient experience to ensure all patients are given the opportunity to Love Life

Our Story

2021

Love Lifesciences founded by Nick Love, MD, MBA and Bradley Hopper after witnessing patient non-compliance

2022

Prototype UNIPEN developed; first functional testing completed.

2023

Launched commericialzation market exploration; filed for XX patents and XX trademarks

2024

Secured FD 510k determination letter; launched partnership with Assoc. for Pharmacy Compounding; began site visits to 503a and 503b prospective launch partners

2025

Secured pre-Series A funding round; initiated limited-market release with three pilot 503a pharmacies; began building prototype of V2 proprietary automated fill-finish system

Guiding Pillars

Patient Centric – Every decision starts with the patient, ensuring our products measurably enhance their experience and outcomes.

Adapt and Pivot – Agility is in our DNA, enabling us to seize new opportunities and outmaneuver entrenched competitors.

Ethical Business Practices– We conduct all operations with uncompromising integrity, honoring the trust 
of patients, colleagues, and investors alike.

Rapidly Learn from Success & Failure [Always Learn, Rapidly] – We grow faster by rigorously extracting lessons from every win, misstep, and shared experience.

Exceed the Standard – Meeting regulations is the baseline; we intentionally outperform industry benchmarks to deliver superior value.

Innovate in Every Aspect – We embed creative thinking across product, business, and regulatory strategy so each breakthrough multiplies its impact.

CORE TEAM

Nick Love, MD, MBA

CO-FOUNDER, CEO

  • Background in Biopharma Business  Analytics & Research
  • Board Member – BioKansas

Bradley Hopper

CO-FOUNDER, CTO

  • 10y founding & growing companies  in various industries
  • Background in Product Design 
&  Engineering

Erik Blume, JD, MBA

Chief Operations Officer

  • 10y+ founding, building, and supporting biosciences and 
deep-tech startups

Sujal Shah

Head of Growth Strategy

  • 20y+ in MedTech commercial 
& market development strategy leadership for Johnson & Johnson, Pfizer

John Ziobro

Head of Regulatory Affairs

  • 35y+ Medical Device expertise including executive management, engineering, regulatory affairs

Richard Hollocher

Product & Systems Engineer

  • Experienced mechanical engineer with a background at Honeywell and Spirit Aerosystems

CLINICAL & SCIENTIFIC ADVISORY BOARD

Rick Couldry, PharmD

  • Chief Pharmacy Officer at The University of Kansas Health System
  • Built >$500M ARR Specialty Pharmacy

Brian Williamson, PharmD

  • Previous Founder & Owner of JCB Laboratories, 503B Pharmacy sold to Fagron

Kyle Gillett, MD

  • Founder of Gillett Health Medical Spa & Concierge Care
  • Specializes in Obesity Medicine & Hormone Replacement Therapy

Tom Krol, PharmD

  • 30y+ Experience in Pharma/Biotech including strategy development, drug development

Selina Gierer, DO

  • Director of Allergy at the University of Kansas Hospital System

Dan Aires, MD, JD

  • Prior Director of Division in Dermatology at The University of Kansas Hospital System
  • CEO of Kanpecia Biotech

Lisa Friis, PhD

  • Director of Product Development Core at KU
  • CTO DirectSync Surgical

COMMERCIAL ADVISORY BOARD

Nancy Forlenza

  • 20y+ in Pharma Sales Management Including Early Stage Experience
  • Sold multiple injectable products including Xyosted by Antares Pharma

Jason Andrews

  • CEO at GemTech Manufacturing
  • Prior Owner/CEO of GroupSource GPO
  • 20y+ in Medical Device Sales

Bryce Davis

  • CEO at Data Insights
  • CEO at Karte Payments & Managing Partner PayCloud innovations

Dave Van Brunt

  • 25y+ Experience as  Marketing Director  & VP of Marketing  at GSK and Bayer

Kevin Lockett

  • Board Member – The  University of Kansas  Hospital System and Kansas City University
  • Managing Partner Fulcrum Global  Capital

Robin Love

  • 20y+ in Pharma/Medical  Device Sales  Management at J&J,  Pfizer, and Novartis
  • Launched 2 Injectable  Products

We work with >130 individuals across a variety of functions including the following organizations

Careers

Transform the Patient Experience with Us

At Love Lifesciences, we’re more than a MedTech company—we’re a mission‑driven team redefining how patients experience care.
We’re looking for people who share our passion for innovation and compassion, and who thrive on solving complex, real‑world challenges
for those who need it most. If you’re ready to merge technology with a patient‑first mindset to make a tangible difference, click
Join Our Team and discover how you can help shape a safer, more personalized future of healthcare.